Introduction
Public, political and media interest in measuring the contribution of health care associated infections to mortality has grown and intensified over the past decade. There are no routine data which directly measure this. Death certificates very rarely state where or how any infection was acquired. Invasive infection with meticillin resistant Staphylococcus aureus (MRSA) is used as one of several indicators of incidence of health care associated infections.
The Office for National Statistics (ONS) has published figures on the numbers of death certificates in England and Wales on which MRSA infection of any body site is mentioned, and the number for which it is selected as the underlying cause of death, annually since 2004, following initial analysis by colleagues at the Health Protection Agency (HPA). 1 The published data series begins in 1993, because it is only from that year that the cause of death text from death certificates and International Classification of Diseases (ICD) codes for all the conditions on the certificate are stored electronically and available for analysis. MRSA infections may be coded to a range of ICD codes, depending on the body site or clinical disease (Boxes One and Two). Some of these codes are specific for Staphylococcus aureus infection (for example, A41.0 septicaemia due to Staphylococcus aureus), but others are not (for example, N39.0 urinary tract infection, site not specified). None of the codes used in mortality coding during the period of this study was specific for meticillin resistance. Identifying death certificates mentioning MRSA infection therefore involves a combination of searching ICD codes and text. MRSA is usually recorded as the underlying cause of death on between a quarter and a third of certificates that mention MRSA at all. 2, 3, 4 The number of death certificates in England and Wales mentioning MRSA showed a steady rise between 1993 and 2005, with a particularly large rise between 2004 and 2005 and a levelling off in 2006. 2, 3, 4 It has been suggested that some of this rise may be due to increased awareness and reporting by certifying doctors and coroners, in response to increased professional and public concern and media attention.
Updated guidance on death certification from the ONS Death Certification Advisory Group (DCAG), including a section on health care associated infections, was published in Association of Clinical Pathologists News in May 2005 5 and on the General Register Office website in June 2005. 6 This was followed by a note from the Chief Medical Officer on certifying deaths involving MRSA in the CMO Update (number 42), which was sent to all registered doctors in July 2005, drawing their attention to the DCAG guidance. 7 There is a popular perception that mortality statistics underestimate the contribution of MRSA to death and that doctors omit MRSA from death certificates because of its perceived links with standards of health care.
There are other reasons why MRSA might not be on the death certificate. Certifiers should only mention those diseases and conditions that contributed to death. 6, 8, 9 MRSA bacteraemia tends to occur in patients who are already seriously ill and have invasive treatment. The certifier may judge that the patient would have died from his underlying disease and/or other complications anyway and that the MRSA bacteraemia did not contribute significantly to the outcome. The certifier may include only the disease or manifestation of infection, for example septicaemia or pneumonia, and not the organism responsible. The certifier may not know the microbiological diagnosis or antibiotic resistance because the patient died before the laboratory report was available or the report was not forwarded on to the certifier when the patient did not die in the hospital where the test was done.
Until now, ONS has only had information from the death certificate, and so could only count deaths with MRSA mentioned. This article describes an analysis of data from national surveillance reports to the HPA of MRSA bacteraemia from laboratories in England which were linked to ONS data from death registrations by HPA as part of a study of mortality following MRSA bacteraemia. The proportion of deaths following laboratory-confirmed MRSA bacteraemia for which MRSA and/or septicaemia is mentioned on the death certificate were determined, and the determinants of whether or not the MRSA infection is mentioned on the certificate were explored.
To test whether doctors are less likely to mention MRSA than other micro-organisms because of its perceived links with health care, the likelihood of having MRSA reported was compared with the likelihood for Streptococcus pneumoniae infection. MRSA is largely hospital acquired, whereas S. pneumoniae is largely community acquired. Though both can give rise to serious disease, MRSA usually does so in patients who are already seriously ill with another condition, whereas S. pneumoniae can do so in previously healthy individuals. Changes in reporting over time were analysed by examining calendar month and year of death, as well as whether the death occurred before or after CMO Update 42. 7 Date of death, not specimen date, was examined in order to look for changes in the practice of doctors and coroners completing certificates. After this univariate analysis, the same variables were assessed controlling for the lag between specimen and death, since deaths in the later part of the study period were likely to have occurred a longer time after the specimen than those at the beginning. The effect of limiting the analysis of changes in reporting over time to a lag period of 2 to 15 days, when certifiers would be likely to have the microbiological diagnosis and the MRSA infection would be at its most acute, was also assessed.
Methods

Records
Results
MRSA
Of the 5,318 laboratory records of MRSA bacteraemia subsequently linked to a death in the two years of the study, MRSA infection at any body site was recorded as the underlying cause of death on 261 certificates (4.9 per cent), and was mentioned on the certificate though not as the underlying cause of death for 498 people (9.4 per cent The proportion of all certificates with MRSA recorded was similar for males (13.9 per cent, 456 deaths) and females (14.9 per cent, 303 deaths). Sex was not related to whether MRSA was mentioned on the death certificate, either before (p= 0.274) or after (p= 0.393) controlling for other determinants (Table 1 and Table 2 ).
The percentage of death certificates mentioning MRSA increased with age from 10.2 per cent between ages 0 and 44 to 17.4 per cent at age 85 and over ( Figure 1 MRSA was recorded on 4.8 per cent of certificates for deaths occurring on the day of, or the day after, the blood specimen was taken. This proportion increased in the period between 2 and 15 days since the specimen to a high of 24.1 per cent, and then declined steadily ( Figure 2 ). Levels of reporting of MRSA on days zero and one were not significantly different from those for day 72 onwards (p=0.264). In all other periods, the likelihood of MRSA being recorded was significantly higher than for day 72 onwards ( 
Changes over time in proportion of linked certificates with MRSA reported
Before controlling for the effects of time between specimen and death, there was no clear increase in the percentage of linked certificates mentioning MRSA over the period of the study (Figure 4) We subsequently re-examined the calendar month, year of death and before/after CMO Update 42 variables, controlling for the effects of the time between specimen and death. This analysis showed a very small, but statistically significant, increase in the chance of MRSA being recorded month on month during the period of the study (OR=1.017, p=0.005) ( Table 3 ). This increase of 1.7 per cent of the level of reporting at the start of the study period (14. Limiting analysis to those deaths occurring between 2 and 15 days since the blood specimen showed similar results ( Calendar month of death was included in the final model (Table 2) , where it showed a very small but statistically significant upward drift in inclusion of MRSA on death certificates, after adjusting for other significant factors. 
Streptococcus pneumoniae
Discussion
Main findings
In this dataset of over 5,000 MRSA bacteraemia laboratory reports linked to death registrations, more certifiers recorded unspecified septicaemia than the organism involved. Almost half of death certificates of patients who died in the first 15 days after their blood culture specimen had either MRSA infection or unspecified septicaemia mentioned. The proportion with mention of MRSA increased significantly with the number of conditions on the certificate and in the oldest age groups. Neither unspecified septicaemia nor MRSA septicaemia would be acceptable as the only cause on a certificate from a doctor without referral to the coroner (Box Six).
Box six
Death Certification and Registration in England and Wales and reporting deaths from septicaemia to the coroner
When someone dies, one of the doctors involved in their care is required under the 1953 Registration of births and deaths Act to complete a medical certificate of cause of death (MCCD), and ensure that it is delivered to the registrar of births and deaths for the area in which the death occurred.
The cause section of the MCCD is in the format internationally agreed through the World Health Assembly, and published by the World Health Organisation in the International Statistical Classification of Diseases, Tenth Revision (ICD-10) which also contains definitions and instructions about how the certificate should be completed. The certifier is asked to start with the immediate cause of death on line a in part I, and then to go back through the sequence of events or conditions that led directly to death on b and c, until s/he gets to the underlying cause of death (UCD). The UCD is defined by WHO as 'a) the disease or condition that initiated the morbid train of events leading directly to death, or b) the external circumstances that caused the fatal injury'. If the certificate has been correctly completed, the UCD should be the single condition written on the lowest used line of the MCCD, and should have caused the conditions written on the lines above it.
The certifying doctor usually gives the completed MCCD to a member of the deceased's family who takes it to the register office. Registrars have a statutory duty to report certain categories of death to the coroner before they can be registered. These include deaths for which the cause appears to be unknown and deaths which might be due to unnatural causes, including any form of accident or violence, injury or poisoning. Registrars have no clinical training. They use their judgement, and instructions provided by the General Register Office to identify deaths that must be referred. An MCCD on which the certifier had only written 'septicaemia' as the underlying cause would be referred to the coroner, because septicaemia could be the result of accidental or violent injury. An MCCD on which the certifier specified that the septicaemia was the result of a disease would not need to be referred, for example septicaemia due to a diverticular abcess due to diverticulitis, or septicaemia due to pneumonia.
There are a small number of organisms that are generally accepted as indicative of a natural illness. For example a death certified as due to meningococcal septicaemia on its own need not be reported to the coroner. However, merely specifying that the septicaemia involved MRSA would not make the certificate acceptable without referral, since this could still be the result of an injury. The certifier would still need to specify a disease that started the sequence leading to the septicaemia, or the death would have to be reported to the coroner. Analysis of changes over time in certification of MRSA Certifiers were significantly more likely to mention MRSA than S. pneumoniae in deaths following positive blood culture with one of these organisms.
When the proportion of linked certificates on which MRSA was mentioned in the two years overall was compared, the difference was not statistically significant, but there was a small statistically significant increase for calendar month. Applying the monthly odds ratio (1.017, The new guidance issued to doctors does not appear to have caused a sustained large increase in the tendency of doctors to mention MRSA.
We did not find any difference in reporting of MRSA in relation to the patient's sex, place of death, certifier of the death, or whether or not a post mortem was carried out.
Comparison with other studies
Other studies have shown that the risk of invasive MRSA infection, 11 and population based mortality rates, 3, 12 rise with age. Mortality from hospital acquired infections also rises with severity of pre-existing disease. 13 This study shows that the likelihood that MRSA will be mentioned on the death certificate when it has been grown from a blood culture also rises with age and with the total number of conditions the certifier thought contributed to death. Some doctors list more steps in the direct sequence leading to death than others, and/or more contributory conditions, given the same scenario, but their reasons for doing this are not known. 14, 15 Studies linking hospital discharge records to death certificates have shown that some conditions are much more likely to be mentioned on the death certificate than others. Life threatening acute events such as stroke and myocardial infarction, as well as cancers of breast and lung, will nearly always be mentioned on the certificate if a patient dies within four weeks of admission for one of these, and will usually be the underlying cause. Acute conditions are more likely to be mentioned if death occurred soon after diagnosis or admission, whereas cancers are likely to be recorded whatever the interval. 16, 17 Our findings on the pattern of MRSA recording by time between specimen and death fit with the pattern seen for acute conditions.
Strengths
This study included all patients in England over a two year period with a first episode of MRSA bacteraemia reported to HPA that could be linked to a death registered in the same period or the subsequent three months. It was able to compare reporting of MRSA with S. pneumoniae, whose acquisition is less associated with health care, following positive blood cultures reported to HPA through a similar voluntary laboratory based system.
Limitations
Very little clinical information is available from the voluntary laboratory reports to HPA or from death certificates. It is not known where or how the infections were acquired, so it cannot be concluded that they were definitely the result of health care interventions or were hospital acquired. The linked dataset was based on voluntary laboratory reports of bacteraemias to HPA. This voluntary scheme is known to be less complete than the mandatory reporting of MRSA bacteraemia, but the latter did not have patient identifiers until near the end of the study period. Other research has shown that blood cultures are only a small proportion of all clinically significant MRSA infections confirmed by microbiology laboratories in hospitals in Oxford. 18 This may explain why only 28 per cent of the deaths could be linked back to a laboratory report.
There was no information on patients' main diagnoses or co-morbidity prior to their septicaemia or death, so reporting of MRSA could not be compared with other diseases, injuries or complications of treatment that the certifiers knew to be present. There was no way of measuring their prior risk of death, nor how much MRSA contributed to it, so it is not known how many deaths should have had MRSA recorded but did not.
Meaning of this study
This study shows that certifiers are most likely to report MRSA or septicaemia on death certificates when patients die during, or very soon after, acute bacteraemic illness, when it is most likely to contribute substantially to risk of death. They report septicaemia, but not MRSA, in the first two days, before laboratory results are available.
Our findings do not support the idea that doctors deliberately omit MRSA from death certificates because of its association with health care. On the contrary, they are more likely to mention MRSA than S. pneumoniae, which is almost always community acquired. Doctors are no less likely to mention MRSA than coroners when completing the death certificate.
The study supports our hypothesis that certifiers more often specify the clinical diagnosis or body system infected, for example septicaemia or pneumonia, than the organism involved. This may be because medical certificates of cause of death (MCCDs) are completed by clinicians caring for patients, rather than microbiologists.
This study cannot tell whether MRSA is actually more likely to contribute to death when patients already have a large number of health problems, or whether it is simply more likely to be mentioned by certifiers who tend to include a large number of conditions.
The MCCD and associated instructions and guidance are designed to identify the underlying cause of death, which is defined by the World Health Organisation (WHO) as '(a) the disease or injury which initiated the morbid train of events leading directly to death, or (b) the circumstances of the accident or violence which produced the fatal injury'. 8 By definition, infections acquired as a result of treatment for another serious disease or injury will not normally be the underlying cause, since they cannot be the start of this sequence. The instructions put much less emphasis on recording conditions other than the underlying cause, and the certifier is only supposed to record those which they believe contributed to the death. MRSA may be only one of many complications of a patient's pre-existing illnesses and the certifier may judge that it made little difference to the patient's risk of dying, given their prior health status, co-morbidity and/or other complications of their underlying condition.
There was a very small, but statistically significant, upward drift in the reporting of MRSA on death certificates following positive bacteraemia specimens during the period of the study. However, the level of upward drift identified here could not explain the level of increase (43. The analysis of changes in reporting following the new DCAG guidance and CMO Update 42 showed that there was no sustained statistically significant difference in reporting before and after the guidance was issued. Any change in reporting immediately after the guidance was issued could just as likely be random variation as a true impact of the guidance.
Of all death certificates with MRSA mentioned in 2004 and 2005, only 28 per cent could be linked to a prior bacteraemia reported to the HPA. The majority of deaths to which certifiers believe MRSA infection made a significant contribution would not be identified from existing national surveillance schemes based on bacteraemia alone. Other researchers have shown that bacteraemia specimens only make up a relatively small proportion of all clinically significant MRSA positive specimens identified in hospital laboratories. 18 There was no information available about laboratory reports of specimens other than blood that might have identified MRSA infection of other body sites in these cases.
This study followed an opportunistic linkage of two existing data systems. Even in combination, these do not actually measure the contribution of MRSA infection to mortality. There is little to be gained from repeatedly linking bacteraemia reports to deaths, unless reports of other clinically significant MRSA infections are also linked and data on principle diagnoses and co-morbidities is collected. Only then would it be possible to estimate the contribution of MRSA infection to death, independent of the certifier's stated clinical opinion.
The laboratory reports available for this study did not include information about where or how the infections were acquired, and this information is very rarely recorded on death certificates. Unless this information is collected systematically, it will not be possible to measure the mortality burden from infections acquired through health care.
Key findings
Certifiers are most likely to record MRSA on the death certificate if • they believe that a large number of conditions contributed to the patient's death, if the patient was aged 75 or over, and if the patient died between 2 and 15 days following a positive blood culture
More certificates mentioned unspecified septicaemia, the clinical • diagnosis, than MRSA, the bacterium involved Almost half of certificates of patients dying within 15 days of a positive • blood culture had either MRSA or unspecified septicaemia mentioned Certifiers were significantly less likely to mention • Streptococcus pneumoniae, a largely community acquired infection, than they were to mention MRSA on the death certificates of patients with a laboratory confirmed bacteraemia There is evidence of a very small upward drift in recording of • MRSA infection by certifiers following a positive blood culture
